Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Incannex Healthcare Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −5 vs. Q1 2022
- Shares held
- 2.23K
- −82.1K (−97.4%) vs. Q1 2022
- Total value
- $8.00K
- −$796.0K (−99.0%) vs. Q1 2022
- New holders
- 0
- 0 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IXHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.71M |
| Q1 2026 | 21 | $3.87M |
| Q4 2025 | 27 | $3.34M |
| Q3 2025 | 28 | $1.76M |
| Q2 2025 | 12 | $220.2K |
| Q1 2025 | 6 | $339.3K |
| Q4 2024 | 7 | $713.8K |
| Q3 2024 | 12 | $879.5K |
| Q2 2024 | 12 | $1.57M |
| Q1 2024 | 15 | $2.30M |
| Q4 2023 | 6 | $1.26M |
| Q3 2023 | 4 | $133.3K |
| Q2 2023 | 2 | $21.5K |
| Q1 2023 | 2 | $44.2K |
| Q4 2022 | 4 | $139.1K |
| Q3 2022 | 5 | $167.0K |
| Q2 2022 | 2 | $8.00K |
| Q1 2022 | 7 | $804.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Incannex Healthcare Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,100 | $4.00K | 0.00% | −18,900−94.5% | Reduced |
| UBS Group AG | 1,132 | $4.00K | 0.00% | −1,625−58.9% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,815−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,016−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,709−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |